NASDAQ:MCRB

Seres Therapeutics Stock Predictions

Healthcare > Biotechnology

Buy MCRB

*Your capital is at risk

$7.17

-0.160 (-2.18%)

At Close: Jun 03, 2026

Currently predicting for Thu, 4 Jun 2026

MCRB Prediction Chart

MCRB Predictions History

Latest community submissions for MCRB.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
JS Pro	Sep 21, 2016	$15.25 +6.20%	$14.36	X	93.80%	0
Fiat @Fiat.751	Aug 29, 2016	$11.05 +1.10%	$10.93	X	98.90%	1
Stockdum Senior	Jun 8, 2016	$32.00 -6.71%	$34.30	X	93.30%	0
JS Pro	Jun 7, 2016	$32.90 +0.34%	$32.79	X	99.70%	4

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for MCRB with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT SERES THERAPEUTICS

Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the treatment of clostridium difficile infection (CDI). It is also developing SER-155, a cultivated bacteri...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
RUN $12.83	18.86%	May 06
GLBE $31.61	5.35%	May 05
SAP $172.39	10.69%	May 05
W WCLD $27.34	27.18%	Apr 29
ADBE $243.57	7.61%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by